SpyGlass Pharma, Inc. Common Stock (SGP) Stock Forecast
Data as of Sep 16, 2026Healthcare · Current price $28.50 (-1.85%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 3, 2026 | Dennis Ding | Jefferies | $62.00 | +117.5% |
Top Analysts Covering SGP
SGP vs Sector & Market
| Metric | SGP | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | — | 2.25 | 2.42 |
| Analyst Count | — | 8 | 18 |
| Target Upside | +39.8% | +16187.2% | +19.5% |
| P/E Ratio | 7.71 | 3.78 | 38.67 |
Frequently Asked Questions
What is the analyst consensus for SGP?
The consensus among 0 analysts covering SpyGlass Pharma, Inc. Common Stock (SGP) is — with an average price target of $62.00.
What is the highest price target for SGP?
The highest price target for SGP is $62.00, set by Dennis Ding at Jefferies on 2026-03-03.
What is the lowest price target for SGP?
The lowest price target for SGP is $62.00, set by Dennis Ding at Jefferies on 2026-03-03.
How many analysts cover SGP?
0 analysts have issued ratings for SpyGlass Pharma, Inc. Common Stock in the past 12 months.
Is SGP a buy or sell right now?
Based on 0 analyst ratings, SGP has a consensus rating of — with a +39.8% upside to the consensus target of $62.00.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.